• 4670 Citations
  • 33 h-Index
1993 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Yeul Hong Kim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 52 Similar Profiles
Stomach Neoplasms Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2013 2019

Research Output 1993 2019

Accuracy and Prognostic Significance of Oncologists’ Estimates and Scenarios for Survival Time in Advanced Gastric Cancer

Vasista, A., Stockler, M., Martin, A., Pavlakis, N., Sjoquist, K., Goldstein, D., Gill, S., Jain, V., Liu, G., Kannourakis, G., Kim, Y. H., Nott, L., Snow, S., Burge, M., Harris, D., Jonker, D., Chua, Y. J., Epstein, R., Bonaventura, A. & Kiely, B., 2019 Jan 1, In : Oncologist.

Research output: Contribution to journalArticle

Stomach Neoplasms
Survival
Oncologists

A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer

Kim, T. Y., Han, H. S., Lee, K. W., Zang, D. Y., Rha, S. Y., Park, Y. I., Kim, J. S., Lee, K. H., Park, S. H., Song, E. K., Jung, S. A., Lee, N. M., Kim, Y. H., Cho, J. Y. & Bang, Y. J., 2019 Jan 1, In : Gastric Cancer.

Research output: Contribution to journalArticle

Paclitaxel
Stomach Neoplasms
Maximum Tolerated Dose
Trastuzumab
HM781-36B

Identification of different gene expressions between diffuse- and intestinal-type spheroid-forming gastric cancer cells

Lee, J. W., Sung, J. S., Park, Y. S., Chung, S. & Kim, Y. H., 2019 Jan 1, In : Gastric Cancer.

Research output: Contribution to journalArticle

Stomach Neoplasms
Gene Expression
Cell Line
Genes
Intestinal Neoplasms
1 Citation (Scopus)

Landscape of actionable genetic alterations profiled from 1,071 tumor samples in Korean cancer patients

Lee, S. H., Lee, B., Shim, J. H., Lee, K. W., Yun, J. W., Kim, S. Y., Kim, T. Y., Kim, Y. H., Ko, Y. H., Chung, H. C., Yu, C. S., Lee, J., Rha, S. Y., Kim, T. W., Jung, K. H., Im, S. A., Moon, H. G., Cho, S., Kang, J. H., Kim, J. & 10 othersKim, S. K., Ryu, H. S., Ha, S. Y., Kim, J. I., Chung, Y. J., Kim, C., Kim, H. L., Park, W. Y., Noh, D. Y. & Park, K., 2019 Jan 1, In : Cancer Research and Treatment. 51, 1, p. 211-222 12 p.

Research output: Contribution to journalArticle

Open Access
Neoplasms
Paraffin
Formaldehyde
Precision Medicine
Workflow

A Phase III Study to Compare the Efficacy and Safety of Paclitaxel Versus Irinotecan in Patients with Metastatic or Recurrent Gastric Cancer Who Failed in First-line Therapy (KCSG ST10-01)

Lee, K. W., Maeng, C. H., Kim, T. Y., Zang, D. Y., Kim, Y. H., Hwang, I. G., Oh, S. C., Chung, J. S., Song, H. S., Kim, J. W., Jeong, S. J. & Cho, J. Y., 2018 Jan 1, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

irinotecan
Paclitaxel
Stomach Neoplasms
Safety
Disease-Free Survival